1. No category

INVITATION
You are cordially invited to the
Third Multidisciplinary Meeting on
Thyroid Cancer:
Controversies in the
Management of Papillary
Thyroid Carcinoma
Wednesday, April 29, 2015
Spencer Auditorium,
Sammy Ofer Tower
Rambam Health Care Campus (HCC)
Bat-Galim, Haifa, Israel
Hosted by:
The Institute of Endocrinology Diabetes and Metabolism, Rambam HCC
The Department of Otolaryngology Head and Neck Surgery, Rambam HCC
The Institute of Oncology, Rambam HCC
The Department of Surgery, Rambam HCC
REGISTER
Parking is available in the new underground parking lot at the main entrance of the
hospital by presenting this invitation.
ORGANIZERS
Sagit Zolotov, MD
Institute of Endocrinology Diabetes and Metabolism, Rambam HCC
Ziv Gil, MD, PhD
Department of Otolaryngology Head and Neck Surgery, Rambam HCC
Salem Billan, MD
Institute of Oncology, Rambam HCC
Michal Mekel, MD
Department of Surgery, Rambam HCC
INTERNATIONAL GUEST SPEAKERS
R Michael Tuttle, MD
Professor of Medicine, Endocrinology Service, Memorial Sloan
Kettering Cancer Center, Cornell University, New York, NY, USA
Ezra E. W. Cohen, MD
Professor of Medicine, Division of Hematology/Oncology,
Moores Cancer Center, University of California San Diego
FACULTY
Gideon Bachar, MD
Department of Otolaryngology, Rabin Medical Center, Petah Tikva
Carlos Benbassat, MD
Institute of Endocrinology, Rabin Medical Center, Petah Tikva
Rahamim Ben Yosef, MD
Director, Radiation Unit, Institute of Oncology, Rambam HCC, Haifa
Salem Billan, MD
Director, Head and Neck Oncology Unit, Institute of Oncology,
Rambam HCC, Haifa
Merav Fraenkel, MD
Endocrine Unit, Soroka Medical Center, Beer Sheva
Diana Gaitini, MD
Director, Ultrasound Unit, Department of Medical Imaging,
Rambam HCC, Haifa
Ziv Gil, MD, PhD
Chairman, Department of Otolaryngology, Rambam HCC, Haifa
Dania Hirsch Kolerman, MD
Institute of Endocrinology, Rabin Medical Center, Petah Tikva
Ben-Zion Joshua, MD
Department of Otolaryngology, Soroka Medical Center,
Beer-Sheva
Michael Krausz MD
Chief of Endocrine Surgery Service, Department of Surgery,
Hillel Yaffe Medical Center, Hadera
Michal Mekel, MD
Endocrine Surgery Service, Department of General Surgery,
Rambam HCC, Haifa
Haitam Nasrallah, MD
Institute of Oncology, Rambam HCC, Haifa
Aron Popovzer, MD
Head, Head and Neck Unit, Davidoff Cancer Center, Rabin Medical
Center, Petah Tikva
Eyal Robenshtok, MD
Institute of Endocrinology, Beilinson Hospital, Rabin Medical
Center, Petah Tikva
Ohad Ronen, MD
Department of Otolaryngology, Galilee Medical Center, Nahariya
Moshe Shabtai, MD
Vice Chairman, Department of Surgery, Head Endocrine Surgery
Service, The Chaim Sheba Medical Center, Tel-Hashomer
Yoav P. Talmi, MD
Director, Head and Neck Service, Department of Otolaryngology,
Sheba Medical Center, Tel-Hashomer
Michal Weiler-Sagie, MD, PhD
Nuclear Medicine Department, Rambam HCC, Haifa
Iris Yaish, MD
Institute of Endocrinology, Tel Aviv Medical Center, Tel Aviv
Jamal Zidan MD
Director, Oncology Institute, Ziv Medical Center, Zefat
Sagit Zolotov, MD
Institute of Endocrinology Diabetes and Metabolism, Rambam HCC
Tzila Zwas, MD
Department of Nuclear Medicine, Hasharon Hospital, Rabin Medical
Center, Petah Tikva
PROGRAM
07:30-08:30 Registration and Refreshments
08:30-09:00 Welcome and Introduction
Karl Skorecki, MD FRCP(C) FASN
Director, Rappaport Research Institute,
Technion - Israel Institute of Technology
Director of Medical and Research
Development, Rambam HCC
Eliezer Shalev MD
Dean, The Ruth & Bruce Rappaport Faculty
of Medicine, Technion-Israel Institute of
Technology
Ziv Gil, MD, PhD, Chairman, Department of
Otolaryngology, Rambam HCC, Haifa
MORNING SESSION I
09:00-09:30 What is the Minimal Surgery for Papillary
Thyroid Cancer?
Pro/Contra Hemithyroidectomy or Total
Thyroidectomy
Ben-Zion Joshua, MD (ENT)
Michal Mekel, MD (Endocrine Surgery)
09:30-10:00 Treatment and Follow-up of Low Risk
Patients:
Pro/Contra Completion Thyroidectomy
Dania Hirsch Kolerman, MD (Endocrinology)
Iris Yaish, MD (Endocrinology)
10:00-10:20 Panel Discussion: Treatment and Follow-up
of Low Risk Patients
Moderator: Ziv Gil, MD, PhD (ENT)
Rahamim Ben Yosef, MD (Oncology)
Michael Krausz MD (Surgery)
R Michael Tuttle, MD (Endocrinology)
Tzila Zwas, MD (Nuclear Medicine)
10:20-10:50 Break
MORNING SESSION II
10:50-11:20 Management of Recurrent/Persistent Nodal
Disease in Patients with Papillary Thyroid
Cancer:
Pro/Contra Surgical Intervention or Active
Surveillance
Merav Fraenkel, MD (Endocrinology)
Eyal Robenshtok, MD (Endocrinology)
11:20-11:50 Surgical Treatment for Papillary Thyroid
Cancer:
Pro/Contra Central Neck Dissection
Ohad Ronen, MD (ENT)
Yoav P. Talmi, MD (ENT)
11:50-12:10 Panel Discussion: Surgical Treatment for
Papillary Thyroid Cancer
Moderator: Ziv Gil, MD, PhD (ENT)
Gideon Bachar, MD (ENT)
Diana Gaitini, MD (Medical Imaging)
Haitam Nasrallah, MD (Oncology)
Moshe Shabtai, MD (Surgery)
R Michael Tuttle, MD (Endocrinology)
12:10-13:00 Management and Follow-up of High Risk
Patients with Papillary Thyroid Cancer
R Michael Tuttle, MD (Endocrinology)
13:00-14:00 Lunch
AFTERNOON SESSION
14:00-14:30 Management of Recurrent/Persistent
Disease in Patients with Papillary Thyroid
Cancer:
Pro/Contra Recurrent Radioiodine
Treatment
Michal Weiler-Sagie, MD, PhD (Nuclear Medicine)
Jamal Zidan, MD (Oncology)
14:30-15:20 The Use of Tyrosine Kinase Inhibitors in
Patients with Papillary Thyroid Cancer
Ezra Cohen, MD (Oncology)
15:20-16:00 Who Should be Treated with Tyrosine
Kinase Inhibitors: Case Discussions
Salem Billan, MD (Oncology)
Aron Popovzer, MD (Oncology)
16:00-16:20 Panel Discussion: The Use of Tyrosine
Kinase Inhibitors in Patients with Papillary
Thyroid Cancer
Moderator: Ziv Gil, MD, PhD (ENT)
Carlos Benbassat, MD (Endocrinology)
Salem Billan, MD (Oncology)
Ezra Cohen, MD (Oncology)
Aron Popovzer, MD (Oncology)
R Michael Tuttle, MD (Endocrinology)
16:20
Closing Remarks
SPONSORS:
Dr. Joel Hamburger
Chair of Internal Medicine and Endocrinology